Monday - May 12, 2025

LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Matinas BioPharma (NYSEAMEX: MTNB)

Follow NYSEAMEX:MTNB Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSEAMEX MTNB Matinas BioPharma
NEUGEBOREN EDWARD / director
04/30/2025
Buy
$0.59
11,600
$7K
11,600
NYSEAMEX MTNB Matinas BioPharma
Smith Robin L / director
04/30/2025
Buy
$0.59
11,600
$7K
11,600
NYSEAMEX MTNB Matinas BioPharma
D An Evelyn / director
04/30/2025
Buy
$0.59
11,600
$7K
11,600
NYSEAMEX MTNB Matinas BioPharma
Jabbour Jerome D / director, officer: President and CEO
04/30/2025
Buy
$0.59
70,100
$41K
70,100
NYSEAMEX MTNB Matinas BioPharma
Murphy Keith / director
04/30/2025
Buy
$0.59
11,600
$7K
11,600
NYSEAMEX MTNB Matinas BioPharma
Sanitam Partners LLC / 10 percent owner
04/08/2025
Buy
$0.64
2.40M
$1.547M
4.80M
NYSEAMEX MTNB Matinas BioPharma
Sanitam Partners LLC / 10 percent owner
04/08/2025
Buy
$0.59
703
$412
1,406
NYSEAMEX MTNB Matinas BioPharma
EIDE ROBERT J / 10 percent owner
04/08/2025
Buy
$0.64
1.68M
$1.082M
3.36M
NYSEAMEX MTNB Matinas BioPharma
EIDE ROBERT J / 10 percent owner
04/08/2025
Buy
$0.59
492
$288
984
NYSEAMEX MTNB Matinas BioPharma
Pembroke & Partners LLC / 10 percent owner
04/08/2025
Buy
$0.64
1.68M
$1.082M
3.36M
NYSEAMEX MTNB Matinas BioPharma
Pembroke & Partners LLC / 10 percent owner
04/08/2025
Buy
$0.59
492
$288
984

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous